GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome.
Saved in:
| Title: | GABA and GLP-1 receptor agonist combination therapy modifies diabetes and Langerhans islet cytoarchitecture in a rat model of Wolfram syndrome. |
|---|---|
| Authors: | Jagomäe, Toomas1 (AUTHOR) toomas.jagomae@gmail.com, Velling, Sandra1 (AUTHOR) sandra.velling@gmail.com, Tikva, Tessa Britt1 (AUTHOR) tessa.britt2013@gmail.com, Maksimtšuk, Varvara1 (AUTHOR) varvaramaksimtsuk@gmail.com, Gaur, Nayana1 (AUTHOR) nayana.gaur@gmail.com, Reimets, Riin1 (AUTHOR) riin.reimets@ut.ee, Kaasik, Allen2 (AUTHOR) allen.kaasik@ut.ee, Vasar, Eero3 (AUTHOR) eero.vasar@ut.ee, Plaas, Mario1 (AUTHOR) mario.plaas@ut.ee |
| Source: | Diabetology & Metabolic Syndrome. 3/6/2025, Vol. 17 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17585996 |
|---|---|
| DOI: | 10.1186/s13098-025-01651-6 |
